Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 166 Triple Negative Breast Neoplasms 54 Neoplasm Metastasis 23 Pancreatic Neoplasms 16 Carcinoma, Non-Small-Cell Lung 15 Ovarian Neoplasms 11 Colorectal Neoplasms 9 Small Cell Lung Carcinoma 8 Sarcoma 8 Neoplasms 8 Lung Neoplasms 8 Prostatic Neoplasms 7 Colonic Neoplasms 7 Breast Neoplasms, Male 7 Stomach Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Parkinson Disease 4, Autosomal Dominant Lewy Body 5 Lymphoma, Non-Hodgkin 5 Cholangiocarcinoma 5 Head and Neck Neoplasms 4 Urinary Bladder Neoplasms 3 Recurrence 3 Rectal Neoplasms 3 Multiple Myeloma 3 Melanoma 3 Kidney Neoplasms 3 Fallopian Tube Neoplasms 3 Endometrial Neoplasms 3 Carcinoma, Renal Cell 3 Uterine Cervical Neoplasms 2

Interventions

Fulvestrant 19 Letrozole 10 Anastrozole 8 Capecitabine 5 palbociclib 4 olaparib 4 Paclitaxel 4 Injections 4 Goserelin 4 Docetaxel 4 trastuzumab deruxtecan 3 pyrotinib 3 exemestane 3 Vinorelbine 3 Aromatase Inhibitors 3 toripalimab 2 sacituzumab govitecan 2 ribociclib 2 eribulin 2 elacestrant 2 dalpiciclib 2 abemaciclib 2 Trastuzumab 2 Gonadotropin-Releasing Hormone 2 FCN-437c 2 Everolimus 2 Dasatinib 2 Alpelisib 2 Albumin-Bound Paclitaxel 2 AZD9833 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Breast Cancer × Gemcitabine × Breast × Clear all

NCT03025880 2023-04-03

PANGEA

Spanish Breast Cancer Research Group

Phase 2 Completed

36 enrolled 28 charts

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡